London, UK, 29 October 2024 - From October 11 to 12, MicroPort® Orthopedics (MPO) hosted the third Global Medial-Pivot Symposium in London. This was the largest medical education event run by the company, drawing more than 300 healthcare professionals from 31 countries.
The symposium was led by a committee of world-renowned orthopedic surgeons, including Dr. Philippe Van Overschelde (Ghent, Belgium), James Nace, DO, FAOAO, MPT (Baltimore, USA), Samuel J MacDessi MBBS (Hons) (Sidney, Australia), Professor John Skinner (Stanmore, UK), and Professor Theofilos Karachalios (Larissa, Hellenic Republic).
The theme of the Symposium is “Medial Pivoting into a New Era” which reflects MPO’s relentless pursuit of delivering personalized patient care by leveraging proven Medial Pivot design and advanced digital technologies.
The first day focused on lectures delivered by renowned global key opinion leaders providing the latest clinical evidence on proven performances of the Medical-Pivot knee kinematics, personalized approach to patient care, and robust advanced technology platform.
The second day consisted of parallel breakout sessions, diving into practical applications of these themes and showcasing MPO’s innovative solutions. Attendees had the opportunity to participate in round-table discussions on difficult cases treated with a medial-pivot knee solution, engage in live debate among faculty members with audience polling questions on alignment approaches, and attend a demo on the SkyWalker® robotic platform followed by a discussion on the importance of data and the role of AI in orthopedics.
Launched in 1998, the MicroPort® Orthopedics Medial-Pivot Knee was one of the first of its kind. Developed through a collaboration between Wright Medical and Dr. J. David Blaha, it represents a breakthrough in knee replacement technology.
Since the MicroPort® Orthopedics Medial-Pivot Knee System was first released more than 25 years ago, it has achieved outstanding clinical success worldwide, with documented 98.8% survivorship at 17 years1, enhanced quadriceps efficiency than traditional PS designs2 and improved patient satisfaction1.
With over 1,000,000 Medial-Pivot Knees implanted, MicroPort® Orthopedics continues to lead the way in surgical innovation. Remaining at the forefront of technological development, the company offers advanced kinematic and personalized alignment instrumented platforms, as well as cutting-edge robotic and augmented reality surgical solutions.
About MicroPort® Orthopedics
MicroPort® Orthopedics, an associated company of MicroPort® (MicroPort Scientific Corporation; HKEX: 00853), leverages over 70 years of experience in orthopedics and excellent clinical results to improve patient outcomes and drive provider satisfaction across the globe. The mission of MicroPort® Orthopedics is to become the trusted partner of healthcare professionals who share a belief that hip and knee replacements of the past are not good enough for the patient today. In partnership with surgeons, MicroPort® Orthopedics helps patients get back on their feet quickly. With a focus on innovation combined with demonstrated capability to deliver the resources of an industry leader, MicroPort® Orthopedics is helping patients worldwide achieve full function faster each and every day.
More information is available at: www.microportortho.com
Reference
1. Based on a retrospective study of Advance® Medial-Pivot. Macheras G.A. et al. A long term clinical outcome of the Medial Pivot Knee Arthroplasty System. The Knee 24 (2017): 447-453.
2. LaMontagne M, et al. Quadriceps and Hamstring Muscle Activation and Function Following Medial Pivot and Posterior Stabilized TKA: Pilot Study.